ClinicalTrials.Veeva

Menu

Accuracy of the Apple Watch Series 4 for Detection of Heart Rhythm: A Pilot Study

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Completed

Conditions

Heart Rate Low
Heart Rate Fast

Treatments

Device: Continuous Telemetry Monitor
Device: Apple Watch 4 Series Device

Study type

Interventional

Funder types

Other

Identifiers

NCT03798613
18-1397

Details and patient eligibility

About

The objective of this study is to assess the accuracy of the Apple Watch 4 Series watch in generating an ECG that is suitable for determination of heart rhythm compared to rhythms monitored via telemetry. Secondary objective is to assess the accuracy of the Apple Watch 4 series watch in identifying atrial fibrillation when it is present.

Full description

The study will assess the accuracy of the Apple watch 4 series watch when worn by post-operative cardiac surgery patients after they have transferred from the ICU to the cardiac telemetry unit.

During testing each subject will wear:

  1. An Apple Watch 4 series watch for no more than 5 minutes.
  2. Standard continuous telemetry monitor

The location of the watch (left or right wrist) will be randomly assigned.

Heart rate and rhythm will be assessed by obtaining tracings from the Apple Watch 4 series watch while at the same point in time obtaining tracings from a standard telemetry monitor.

ECGs from the Apple Watch 4 will be collected by asking the patient to place his/ her finger on the digital crown of the Apple Watch 4 for 30 seconds. The rhythm displayed by the Apple Watch 4 will be viewed on the Apple health app (available on the iPhone 8) and will be saved for subsequent viewing and analysis.

Each enrolled patient will have a minimum of three assessments of heart rhythm per day for at least two days, generating a minimum of six data points per patient.

After conclusion of the study for each subject, the ECG's from the health app pertaining to that subject will be reviewed by a board certified cardiologist as will the telemetry tracings.

In order to obtain tracings of new onset post-operative atrial fibrillation. 50% of the subjects enrolled will be in sinus rhythm and 50% will be in atrial fibrillation at the time of enrollment.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • Post-operative cardiac surgery patients on the cardiac telemetry floors at the Cleveland Clinic Main Campus

Exclusion criteria

  • Presence of a cardiac pacemaker
  • Use of a radial artery graft for coronary artery bypass grafting
  • Tattoos located on the skin of the wrist or forearm where the Apple Watch 4 will be placed

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Apple Watch 4 Series Device
Active Comparator group
Description:
Apple watch 4 series heart rate monitoring device
Treatment:
Device: Apple Watch 4 Series Device
Continuous Telemetry
Active Comparator group
Description:
Standard continuous telemetry monitoring device
Treatment:
Device: Continuous Telemetry Monitor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems